November 7, 2014 / 1:23 PM / 3 years ago

BUZZ-Tekmira Pharmaceuticals: Ebola treatment for U.S. Defense

1 Min Read

** Canadian drugmaker's U.S.-listed shares up 6 pct at $16.72 premarket

** Says on Thursday U.S. Department of Defense exercised an option for the company to make 500 courses of its experimental treatment for Ebola

** Up to Thursday's close, stock had fallen about 25 pct since Sept. 30, when the first patient was diagnosed with Ebola in the United States

** TAKE A LOOK-World On Alert To Contain Ebola Outbreak

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below